FORM OF PRE-FUNDED WARRANT] GT BIOPHARMA, INC. Pre-Funded Warrant To Purchase Common StockPre-Funded Warrant • February 2nd, 2021 • GT Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 2nd, 2021 Company Industry JurisdictionGT Biopharma, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, ______________, the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), the number of fully paid non-assessable shares of Common Stock set forth above, subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Pre-Funded Warrant to Purchase Common Stock (including any Pre-Funded Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), shall have the meanings set forth in Section 17.
FORM OF PRE-FUNDED WARRANT] ALTIMMUNE, INC. PRE-FUNDED WARRANT TO PURCHASE COMMON STOCKPre-Funded Warrant • September 28th, 2018 • Altimmune, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 28th, 2018 Company Industry JurisdictionAltimmune, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after [ ] (the “Initial Exercisability Date”), until exercised in full (the “Termination Date”), ( ) fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Pre-Funded Warrant to Purchase Common Stock (including any Pre-Funded Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), shall have the meanings set forth in Section 16. This Warrant is one of the Warrants to Purchase Common St
FORM OF PRE-FUNDED WARRANT] ALTIMMUNE, INC. PRE-FUNDED WARRANT TO PURCHASE COMMON STOCKPre-Funded Warrant • September 26th, 2018 • Altimmune, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 26th, 2018 Company Industry JurisdictionAltimmune, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after [ ] (the “Initial Exercisability Date”), until exercised in full (the “Termination Date”), ( ) fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Pre-Funded Warrant to Purchase Common Stock (including any Pre-Funded Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), shall have the meanings set forth in Section 16. This Warrant is one of the Warrants to Purchase Common St